181 related articles for article (PubMed ID: 31417563)
1. Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression
Schmetterer KG; Goldhahn K; Ziegler LS; Gerner MC; Schmidt RLJ; Themanns M; Zebedin-Brandl E; Trapin D; Leitner J; Pickl WF; Steinberger P; Schwarzinger I; Marculescu R
Front Immunol; 2019; 10():1790. PubMed ID: 31417563
[TBL] [Abstract][Full Text] [Related]
2. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cAMP degradation improves regulatory T cell-mediated suppression.
Bopp T; Dehzad N; Reuter S; Klein M; Ullrich N; Stassen M; Schild H; Buhl R; Schmitt E; Taube C
J Immunol; 2009 Apr; 182(7):4017-24. PubMed ID: 19299699
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25
Chen Z; Yang Y; Neo SY; Shi H; Chen Y; Wagner AK; Larsson K; Tong L; Jakobsson PJ; Alici E; Wu J; Cao Y; Wang K; Liu LL; Mao Y; Sarhan D; Lundqvist A
EMBO Rep; 2021 Mar; 22(3):e51329. PubMed ID: 33480074
[TBL] [Abstract][Full Text] [Related]
5. Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression.
Sasi B; Ethiraj P; Myers J; Lin AP; Jiang S; Qiu Z; Holder KN; Aguiar RCT
Leukemia; 2021 Jul; 35(7):1990-2001. PubMed ID: 33299141
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
8. Type 4A cAMP-specific phosphodiesterase is stored in granules of human neutrophils and eosinophils.
Pryzwansky KB; Madden VJ
Cell Tissue Res; 2003 Jun; 312(3):301-11. PubMed ID: 12764607
[TBL] [Abstract][Full Text] [Related]
9. microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance.
Anandagoda N; Willis JC; Hertweck A; Roberts LB; Jackson I; Gökmen MR; Jenner RG; Howard JK; Lord GM
J Clin Invest; 2019 Mar; 129(3):1257-1271. PubMed ID: 30741720
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac.
Vang AG; Housley W; Dong H; Basole C; Ben-Sasson SZ; Kream BE; Epstein PM; Clark RB; Brocke S
Biochem J; 2013 Dec; 456(3):463-73. PubMed ID: 24007532
[TBL] [Abstract][Full Text] [Related]
11. The role of cyclic adenosine monophosphate in the suppression of cellular immunity after thermal injury.
Horgan AF; O'Riordain DS; Chin DH; Mannick JA; Rodrick ML
Arch Surg; 1994 Dec; 129(12):1284-9. PubMed ID: 7986157
[TBL] [Abstract][Full Text] [Related]
12. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
13. Role of AKAP 149-PKA-PDE4A complex in cell survival and cell differentiation processes.
Fernández-Araujo A; Tobío A; Alfonso A; Botana LM
Int J Biochem Cell Biol; 2014 Aug; 53():89-101. PubMed ID: 24813785
[TBL] [Abstract][Full Text] [Related]
14. The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).
Whiteside TL; Mandapathil M; Schuler P
Curr Med Chem; 2011; 18(34):5217-23. PubMed ID: 22087822
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviation.
He H; Yang P; Jiang L; Zhang J; Zhao C; Chen L; Lin X; Zhou H; Kijlstra A
BMC Immunol; 2008 Sep; 9():53. PubMed ID: 18816417
[TBL] [Abstract][Full Text] [Related]
16. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets.
Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D
Front Immunol; 2019; 10():475. PubMed ID: 30936876
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5'-monophosphate-mediated signaling pathways.
Gerlo S; Verdood P; Gellersen B; Hooghe-Peters EL; Kooijman R
J Immunol; 2004 Nov; 173(10):5952-62. PubMed ID: 15528329
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
19. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs.
Rubio MT; Means TK; Chakraverty R; Shaffer J; Fudaba Y; Chittenden M; Luster AD; Sykes M
Int Immunol; 2005 Dec; 17(12):1561-72. PubMed ID: 16303787
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activated T cells display increased sensitivity to PGE2.
Sunder-Plassmann R; Majdic O; Knapp W; Holter W
Cell Immunol; 1991 Dec; 138(2):289-99. PubMed ID: 1657408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
